|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Intestinal metaplasia, high-grade epithelial dysplasia and gastric cancer 显示文摘 | TESTINO G CONRAGGIA M DE LACO F | 2002 | Scand J Gastroenterol2002，37，12： | 1 |
| 2 | Use of camptothecin-resistant mammalian cell lines to evaluate the role of topoisomerase I in the antiproliferative activity of the indolocarbazole, NB-506, and its topoisomerase I binding site 显示文摘 | URASAKI Y LACO G TAKEBAYASHI Y | 2001 | Cancer Res2001，61，2： | 1 |
| 3 | Use ofcamptothecin-resistant mammalian cell lines to evaluate the role of topoisomerase I in the antiproliferative activity of the indolocarbazole, NB-506,and its topoisomerase I binding site 显示文摘 | URASAKI Y LACO G TAKEBAYASHI Y | 2001 | Cancer Res2001，61，2： | 1 |
| 4 | Use of camptothecin- resistant mammalian cell lines to evaluate the role of topoi- somerase I in the antiproliferative activity of the indolocarba zole, NB-506, and its topoisomerase I binding site显示文摘 | Urasaki Y Laco G Takebayashi Y | 2001 | Cancer Res2001，61，2： | 1 |
| 5 | Use of camptothecin-resistant mammalian cell activity of the role of topoisomerase I in the antiproliferative activity of the indolocarbazole,NB-506,and its topoisomerase I binding site显示文摘 | Urasaki Y Laco G Takebayashi Y | | 0，，21： | 1 |
| 6 | Characteriza- tion of a novel topoisomerase I mutation from a camptothecin - re- sistant human prostate cancer cell line显示文摘 | URASAKI Y LACO G S POURQUIER P | 2001 | Cancer Res2001，61，5： | 1 |
| 7 | Use of camptothecin - resistant mammalian cell lines to evaluate the role of topoisomerase Ⅰ in the antiproliferative activity of the indolocarbazole, NB - 506, and its topoisomerase Ⅰ binding site显示文摘 | Urasaki Y Laco G Takebayashi Y | 2001 | Cancer Res2001，61，2： | 1 |
| 8 | Human topoisomerase I inhibition : docking camptothecin and derivates into a structure-based active site model显示文摘 | LACO G S COLLONS J R | 2002 | Biochemistry2002，41，5： | 1 |
| 9 | Human topoisomerase Ⅰ inhibition:docking camptothecin and derivatives into a structurebased active site model显示文摘 | Laco G S Collins J R Luke B T | 2002 | Biochemistry2002，41，5： | 1 |
| 10 | 显示文摘 | LACO G S DU W KOHLHAGEN G | 2004 | Bioorganic : Medicinal Chemistry2004，12，19： | 1 |
| 11 | Off or on-pump bypass:what is the safty threshold显示文摘 | Laco AL Contini M Teodori G | 1999 | Ann Thorac Surg1999，68，5： | 1 |
| 12 | Use of camptothecin-resistant mammalian cell lines to evaluate the role of topoisomerase I in the antiproliferative activity of the indolocarbazole, NB-506, and its topoisomerase I binding site 显示文摘 | Urasaki Y Laco G Takebayashi Y | 2001 | Cancer Res2001，61，2： | 1 |
| 13 | A combined seismic reflection and refraction study of a landfill and its host sediments 显示文摘 | De laco R Green A G Maurer H R | 2003 | Geoph J2003，52，： | 1 |
| 14 | Helicobacter pylori influence on gastric acid secretion in duodenal ulcer patients diagnosed for the frist time显示文摘 | TESTINO G CORNAGGIA M De LACO F | 2002 | Panminerva Med2002，44，： | 1 |
| 15 | Use of camptoth- ecin-resistant mammalian cell lines to evaluate the role of topoisomerase I in the antiproliferative activity of the indolocarbazole, NB-506, and its topoisomerase I binding site 显示文摘 | Urasaki Y Laco G Takebayashi Y | 2001 | Cancer Res2001，61，2： | 1 |
| 16 | Use of camptothecin-resistant mammalian cell activity of the role of topoisomerase I in the antiproliferative activity of the indolocarbazole,NB-506,and its topoisomerase I binding site显示文摘 | Urasaki Y Laco G Takebayashi Y | 2001 | Cancer Res2001，61，2： | 1 |
| 17 | Human topoisomer-aseⅠinhibition:docking camptothecin and derivatives into a structure-based active site model显示文摘 | Laco G S Collins J R Luke B T | 2002 | Biochemistry2002，41，5： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员